Filing Details

Accession Number:
0001432676-10-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-11 12:00:00
Reporting Period:
2010-03-10
Filing Date:
2010-03-11
Accepted Time:
2010-03-11 17:01:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884624 Orthofix International N V OFIX Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314333 Eric Brown 800 Boylston Street
Prudential Tower
Boston MA 02199
President, Spinal Stimulation No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-03 2,802 $13.03 7,802 No 5 J Direct
Common Stock Disposition 2010-03-10 600 $36.01 7,202 No 4 S Direct
Common Stock Disposition 2010-03-10 2,202 $35.39 5,000 No 4 S Direct
Common Stock Acquisiton 2010-03-10 6,334 $28.95 11,334 No 4 M Direct
Common Stock Acquisiton 2010-03-10 1,667 $10.42 13,001 No 4 M Direct
Common Stock Disposition 2010-03-10 6,334 $35.39 6,667 No 4 S Direct
Common Stock Disposition 2010-03-10 1,667 $35.39 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 J Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-03-10 6,334 $0.00 6,334 $28.95
Common Stock Stock Option (right to buy) Disposition 2010-03-10 1,667 $0.00 1,667 $10.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,666 2018-06-30 No 4 M Direct
3,333 2018-11-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,522 Indirect Irrevocable Trust
Footnotes
  1. Shares acquired under the company's Stock Purchase Plan on 2/03/2010.
  2. Price per share was set at the beginning of the SPP reporting period.
  3. The Reporting Person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Stock sale price range is from $35.00 to $35.98.
  5. The options vest in one-third increments on each of the first, second, and third anniversaries of the grant date of June 30, 2008.
  6. The options vest in one-third increments on each of the first, second, and third anniversaries of the grant date of November 21, 2008.